Treatment of neuroblastoma by inhibition of sphingosine kinase
Ended Project Grant Awarded Last action
- Award ID
- R43CA235804
- Recipient
-
Apogee Biotechnology Corporation UEI J9Q4KEGSLWY9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $225,000
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Hummelstown, PA 17036, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $225,000 |
Quick answers
Who received award R43CA235804?
R43CA235804 was awarded to Apogee Biotechnology Corporation by National Cancer Institute (National Institutes of Health) on August 1, 2019.
How much is award R43CA235804 worth?
$225,000 has been obligated on R43CA235804.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award